Akèy › Maladi Crohn › Florid

Etid klinik pou Maladi Crohn nan Florid

27 etid pou Maladi Crohn ap chèche patisipan nan sit nan Florid.

Vil nan Florid

Tèks ofisyèl etid la (Anglè)

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Access Research Institute, Brooksville
Gastro Florida, Clearwater
Digestive and Liver Center of Florida, P.A., Kissimmee
ak 5 plis

Ap rekriteFaz 4

Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Covenant Metabolic Specialists, LLC ( Site 5150), Fort Myers
Nature Coast Clinical Research - Inverness ( Site 5042), Inverness
Sanchez Clinical Research ( Site 5144), Miami
ak 4 plis

Ap rekriteFaz 3

Laj 16 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Synergy Healthcare - Bradenton - 17th Avenue West /ID# 284157, Bradenton
Clinical Research of Osceola /ID# 280593, Kissimmee
Florida Center For Gastroenterology - Largo /ID# 281059, Largo
ak 3 plis

Ap rekriteFaz 2

Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07697456

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

American Institute of Research, Cutler Bay
Nature Coast Clinical Research, Inverness
Florida Research Center Inc., Lakewood Rch
ak 2 plis

Ap rekriteFaz 2/3

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196722

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Green Leaf Clinical Trials, Jacksonville
Sanchez Clinical Research, Inc, Miami
Biodax Medical Research Trials, Miami
ak 2 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07499232

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

West Central Gastroenterology, LLP, d/b/a/ Gastro Florida, Clearwater
Auzmer Research, Lakeland
Wellness Clinical Research, Miami Lakes
ak 3 plis

Ap rekriteFaz 2

Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06233461

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Novum Research /ID# 278128, Clermont
University of Florida College of Medicine /ID# 266930, Gainesville
Nature Coast Clinical Research - Inverness /ID# 265874, Inverness
ak 9 plis

Ap rekriteFaz 2

Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06548542

Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease

University of Miami, Miami

Ap rekrite

Laj 16 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT07671872

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Research Associates of South Florida - Miami - Southwest 8th Street, Miami
Gastro Health Research - Miami, Miami
Orlando Health, Orlando
ak 3 plis

Ap rekriteFaz 3

Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Novum Research, LLC-Site Number: 8400003, Clermont
Sarkis Clinical Trials - Gainesville-Site Number: 8400048, Gainesville
Clinical Research of Osceola-Site Number: 8400013, Kissimmee
ak 12 plis

Ap rekriteFaz 3

Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando

Ap rekriteFaz 3

Laj 2 a 17 · Tout sèks · Mizajou Sep 23, 2026 · NCT05995353

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Clinical Research of Osceola-Site Number: 8400013, Kissimmee
Columbus Clinical Services LLc-Site Number: 8400038, Miami
Bioresearch Partner-Kendale Lakes-Site Number: 8400053, Miami
ak 2 plis

Ap rekriteFaz 3

Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184944

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Gastro Health Research - Miami, Miami
Ezy Medical Research, Miami Lakes

Ap rekriteFaz 2

Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07483073

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Gastro Health Research - Miami, Miami
Ezy Medical Research, Miami Lakes

Ap rekriteFaz 2

Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Clinical Research of Osceola, Kissimmee
Bioresearch Partner-Kendale Lakes, Miami
Endoscopic Research Inc, Orlando
ak 1 plis

Ap rekriteFaz 2

Laj 18 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT06226883

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Clinical Research of Osceola, Kissimmee
Endoscopic Research Inc, Orlando
Alliance Clinical Research of Tampa, LLC, Tampa

Ap rekriteFaz 4

Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Florida Research Center Inc., Lakewood Rch
Sanchez Clinical Research, Inc, Miami
GCP Clinical Research, Tampa

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07577843

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Mayo Clinic Jacksonville, Jacksonville
Advent Health, Orlando

Ap rekrite

Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

University of Miami, Miami
AdventHealth, Orlando

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07237516

Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

Digestive & Liver Center of Florida, Orlando

Ap rekriteFaz 4

Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT06997965

Precise Infliximab Exposure and Pharmacodynamic Control

Nemours Children's Health System-Jacksonville, Jacksonville

Ap rekriteFaz 2/3

Laj 6 a 22 · Tout sèks · Mizajou May 5, 2026 · NCT05660746

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Clinical Research Of Brandon, LLC, Brandon
West Central Gastroenterology d/b/a Gastro Florida, Clearwater
Auzmer Research, Lakeland
ak 7 plis

Ap rekriteFaz 2

Laj 18 a 75 · Tout sèks · Mizajou Apr 27, 2026 · NCT06456593

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

University of Miami, Miami

Ap rekriteFaz 4

Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT06774079

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Investigational Site Number: 8400017, Kissimmee
Investigational Site Number: 8400015, Lighthouse PT
Investigational Site Number 8400028, Miami
ak 3 plis

Ap rekriteFaz 2

Laj 18 a 75 · Tout sèks · Mizajou Mar 27, 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mirador Therapeutics Selected Site, Miami
Mirador Therapeutics Selected Site, Miami
Mirador Therapeutics Selected Site, Miami
ak 3 plis

Ap rekriteFaz 2

Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease

Mayo Clinic Florida, Jacksonville

Ap rekrite

Laj 18 a 70 · Tout sèks · Mizajou Feb 17, 2026 · NCT06647615

Treatment of Moderate to Severe Refractory Crohn's Disease

University of Florida, Gainesville

Ap rekriteFaz 1/2

Laj 18 a 65 · Tout sèks · Mizajou Dec 10, 2025 · NCT06721962

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.